2024 Endocrinology Grand Rounds | Rethinking the Limits of Surgery for Invasive Pituitary Adenomas
Pituitary adenomas are a common endocrine issue, and it is vital that clinicians have the knowledge and tools to discuss with patients, what surgical techniques are available to treat their disease, if and when appropriate. Patients deserve to know the most up to date and innovative surgical techniques in order to minimize complications. As such, there is a need for a tight collaboration between endocrinology and surgical teams, which will result in improvement in patient care outcomes and quality of care delivered.
Surgical fields are always advancing and we depend on our surgical colleagues to keep us updated on best, innovative techniques, in order to improve patient care. It is imperative to stay abreast of the advances in surgical techniques for pituitary neuroendocrine tumors. This will also help to appropriately refer to neurosurgery and what to monitor for pre and post operatively.
Target Audience
Faculty and Staff of department of Diabetes, Endocrinology and Metabolism.
Learning Objectives
- Identify the proper time and urgency to refer patients to neurosurgery for invasive pituitary tumors.
- Educate patients on innovative surgical techniques when pituitary adenomas require surgical resection.
- Outline potential post-operative complications after surgery of pituitary neuroendocrine tumors.
- Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
Virtual Meeting- Zoom
Ahmed Mohyeldin, MD, PhD Assistant Professor of Neurosurgery; Co-Director of the Endoscopic Skull Base and Pituitary Program; University of California-Irvine
Presenter: Dr. Mohyeldin has indicated that there are no relevant financial relationships.
Planner: Pooja Manroa, MD has indicated that there are no relevant financial relationships.
This presentation and/or comments will provide a balanced, non-promotional, and evidence-based approach to all diagnostic, therapeutic and/or research related content.
CME Committee/Reviewer no relevant financial relationships: Daneng Li, MD
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1 Credit™ 1.0
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
Available Credit
- 1.00 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this 2024 Endocrinology Grand Rounds | Rethinking the Limits of Surgery for Invasive Pituitary Adenomas for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 1.00 Attendance